Cargando…

A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification

PURPOSE: To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification. METHODS: A total of 656 patients who underwent SSNs resection were retrospectively enrolled. Among them, 407 patients were assigned to the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Qilong, Song, Biao, Li, Xiaohu, Wang, Bin, Li, Yuan, Chen, Wu, Wang, Zhaohua, Wang, Xu, Yu, Yongqiang, Min, Xuhong, Ma, Dongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446567/
https://www.ncbi.nlm.nih.gov/pubmed/36064495
http://dx.doi.org/10.1186/s40644-022-00483-1
_version_ 1784783669615919104
author Song, Qilong
Song, Biao
Li, Xiaohu
Wang, Bin
Li, Yuan
Chen, Wu
Wang, Zhaohua
Wang, Xu
Yu, Yongqiang
Min, Xuhong
Ma, Dongchun
author_facet Song, Qilong
Song, Biao
Li, Xiaohu
Wang, Bin
Li, Yuan
Chen, Wu
Wang, Zhaohua
Wang, Xu
Yu, Yongqiang
Min, Xuhong
Ma, Dongchun
author_sort Song, Qilong
collection PubMed
description PURPOSE: To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification. METHODS: A total of 656 patients who underwent SSNs resection were retrospectively enrolled. Among them, 407 patients were assigned to the derivation cohort and 249 patients were assigned to the validation cohort. Univariate and multi-variate logistic regression algorithms were utilized to identity independent risk factors of adenocarcinomas. A nomogram based on the risk factors was generated to predict the risk of adenocarcinomas. The discrimination ability of the nomogram was evaluated using the concordance index (C-index), its performance was calibrated using a calibration curve, and its clinical significance was evaluated using decision curves and clinical impact curves. RESULTS: Lesion size, mean CT value, vascular change and lobulation were identified as independent risk factors for adenocarcinomas. The C-index of the nomogram was 0.867 (95% CI, 0.833-0.901) in derivation cohort and 0.877 (95% CI, 0.836-0.917) in validation cohort. The calibration curve showed good agreement between the predicted and actual risks. Analysis of the decision curves and clinical impact curves revealed that the nomogram had a high standardized net benefit. CONCLUSIONS: A nomogram for predicting the risk of adenocarcinomas in patients with SSNs was established in light of the 2021 WHO classification. The developed model can be adopted as a pre-operation tool to improve the surgical management of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-022-00483-1.
format Online
Article
Text
id pubmed-9446567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94465672022-09-07 A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification Song, Qilong Song, Biao Li, Xiaohu Wang, Bin Li, Yuan Chen, Wu Wang, Zhaohua Wang, Xu Yu, Yongqiang Min, Xuhong Ma, Dongchun Cancer Imaging Research Article PURPOSE: To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification. METHODS: A total of 656 patients who underwent SSNs resection were retrospectively enrolled. Among them, 407 patients were assigned to the derivation cohort and 249 patients were assigned to the validation cohort. Univariate and multi-variate logistic regression algorithms were utilized to identity independent risk factors of adenocarcinomas. A nomogram based on the risk factors was generated to predict the risk of adenocarcinomas. The discrimination ability of the nomogram was evaluated using the concordance index (C-index), its performance was calibrated using a calibration curve, and its clinical significance was evaluated using decision curves and clinical impact curves. RESULTS: Lesion size, mean CT value, vascular change and lobulation were identified as independent risk factors for adenocarcinomas. The C-index of the nomogram was 0.867 (95% CI, 0.833-0.901) in derivation cohort and 0.877 (95% CI, 0.836-0.917) in validation cohort. The calibration curve showed good agreement between the predicted and actual risks. Analysis of the decision curves and clinical impact curves revealed that the nomogram had a high standardized net benefit. CONCLUSIONS: A nomogram for predicting the risk of adenocarcinomas in patients with SSNs was established in light of the 2021 WHO classification. The developed model can be adopted as a pre-operation tool to improve the surgical management of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40644-022-00483-1. BioMed Central 2022-09-05 /pmc/articles/PMC9446567/ /pubmed/36064495 http://dx.doi.org/10.1186/s40644-022-00483-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Song, Qilong
Song, Biao
Li, Xiaohu
Wang, Bin
Li, Yuan
Chen, Wu
Wang, Zhaohua
Wang, Xu
Yu, Yongqiang
Min, Xuhong
Ma, Dongchun
A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title_full A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title_fullStr A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title_full_unstemmed A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title_short A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification
title_sort ct-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 who classification
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446567/
https://www.ncbi.nlm.nih.gov/pubmed/36064495
http://dx.doi.org/10.1186/s40644-022-00483-1
work_keys_str_mv AT songqilong actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT songbiao actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT lixiaohu actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangbin actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT liyuan actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT chenwu actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangzhaohua actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangxu actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT yuyongqiang actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT minxuhong actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT madongchun actbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT songqilong ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT songbiao ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT lixiaohu ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangbin ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT liyuan ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT chenwu ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangzhaohua ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT wangxu ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT yuyongqiang ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT minxuhong ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification
AT madongchun ctbasednomogramforpredictingtheriskofadenocarcinomasinpatientswithsubsolidnoduleaccordingtothe2021whoclassification